SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-21-000055
Filing Date
2021-04-08
Accepted
2021-04-07 18:01:19
Documents
4
Period of Report
2021-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k04072021_leerink.htm 8-K 31693
2 EX-1.1 ex11_2021atm-atmsalesagree.htm EX-1.1 319060
3 EX-5.1 dare-51opinionatm.htm EX-5.1 14329
4 image_01.jpg GRAPHIC 282017
  Complete submission text file 0001401914-21-000055.txt   754777
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 21813242
SIC: 2834 Pharmaceutical Preparations